86 related articles for article (PubMed ID: 690428)
1. Immunity to experimental Salmonella infection: studies on the protective capacity and immunogenicity of lipopolysaccharide, acetone-killed cells, and ribosome-rich extracts of Salmonella typhimurium in C3H/HeJ and CD-1 mice.
Eisenstein TK; Angerman CR
J Immunol; 1978 Sep; 121(3):1010-4. PubMed ID: 690428
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
3. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
Schafer R; Nacy CA; Eisenstein TK
J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
[TBL] [Abstract][Full Text] [Related]
4. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
Schlecht S
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
[TBL] [Abstract][Full Text] [Related]
5. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
Lin JH; Berry LJ
J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
[No Abstract] [Full Text] [Related]
6. [Experimental protective immunization of mice against S. typhimurium infection by Salmonella R mutants].
Schlecht S
Zentralbl Bakteriol Orig A; 1974; 227(1-4):250-6. PubMed ID: 4154594
[No Abstract] [Full Text] [Related]
7. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
Jirillo E; Kiyono H; Michalek SM; McGhee JR
J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051
[TBL] [Abstract][Full Text] [Related]
8. Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235.
Killar LM; Eisenstein TK
J Immunol; 1984 Sep; 133(3):1190-6. PubMed ID: 6379046
[TBL] [Abstract][Full Text] [Related]
9. Compared efficiency of a killed vaccine of Salmonella typhimurium, a live vaccine and an antigenic fraction in oral immunization of mice.
Fontanges R; Ivanoff B; Creach O
Dev Biol Stand; 1976; 33():118-23. PubMed ID: 782961
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
11. Relationship between protective immunity, mitogenicity, and B cell activiation by Salmonella vaccines.
Eisenstein TK; Angerman CR; O'Donnell S; Specter S; Friedman H
Adv Exp Med Biol; 1979; 121B():39-50. PubMed ID: 397755
[No Abstract] [Full Text] [Related]
12. Localization of the protective antigen in Salmonella typhimurium.
Mates A; Yosipovici H
Microbios; 1976; 16(64):81-90. PubMed ID: 800632
[TBL] [Abstract][Full Text] [Related]
13. Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.
Misfeldt ML; Johnson W
Infect Immun; 1977 Jul; 17(1):98-104. PubMed ID: 328399
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.
Angerman CR; Eisenstein TK
Infect Immun; 1978 Feb; 19(2):575-82. PubMed ID: 344216
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.
Angerman CR; Eisenstein TK
Infect Immun; 1980 Feb; 27(2):435-43. PubMed ID: 6991415
[TBL] [Abstract][Full Text] [Related]
17. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice.
Sagi SS; Paliwal P; Bansal A; Mishra C; Khan N; Mustoori SR; Ilavazhagan G; Sawhney RC; Banerjee PK
Vaccine; 2006 Nov; 24(49-50):7135-41. PubMed ID: 16887241
[TBL] [Abstract][Full Text] [Related]
18. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice.
Eisenstein TK; Killar LM; Stocker BA; Sultzer BM
J Immunol; 1984 Aug; 133(2):958-61. PubMed ID: 6376631
[TBL] [Abstract][Full Text] [Related]
20. Hemopoietic responses of LPS-unresponsive C3H/HeJ mice to salmonella infection.
Miyanomae T; Mori KJ; Seto A
Biomed Pharmacother; 1983; 37(2):65-8. PubMed ID: 6616033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
